• 12 Dec 19

Faron Pharmaceuticals makes 'groundbreaking discovery' in its MATINS trial

Faron Pharmaceuticals makes 'groundbreaking discovery' in its MATINS trial

Faron Pharmaceuticals Oy | FARN | 222 2.5 0.0%

    • 171 views

 

Faron Pharmaceuticals Oy (LON:FARN) (FIRSTNORTH:FARON) CEO Dr Markku Jalkanen speaks to Proactive London's Andrew Scott after updating on its phase I/II MATINS trial of Clevegen.

He says it's been encouraging to discover that Clevegen can ‘down’ regulate a range of checkpoints that affect the immune system.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Faron Pharmaceuticals presents promising data at ASCO 2025 conference patients

Companies: Faron Pharmaceuticals Oy

Morning Report: Faron Pharma expands MATINS trial to include ovarian cancer

Companies: Faron Pharmaceuticals Oy

Faron Pharmaceuticals raises €12M in pivotal year for BEXMAB trials

Companies: Faron Pharmaceuticals Oy

Faron Pharmaceuticals CEO details £12mln fundraise and new WHO coronavirus trial

Companies: Faron Pharmaceuticals Oy

Faron Pharmaceuticals, ANGLE, Ananda Pharma, BenevolentAI, Andrada Mining - Small Cap Snapshot

Companies: Faron Pharmaceuticals Oy

Faron Pharma CEO confident as he looks ahead to new Traumakine study

Companies: Faron Pharmaceuticals Oy

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top